Here's your morning TNB Tech Minute for Monday, February 23rd. I'm Julie Chang for the Wall Street Journal.

Gilead Sciences has agreed to buy the rest of development partner Arcelix in a deal that values the

biotech company at about $7.8 billion at closing. Gilead said it will pay an initial $115 a share in cash for the 88.5% of Arcelix it doesn't

already own, a 79% premium to Friday's closing price. Biopharmaceutical company, Gilead and

Arcelic struck a deal in 2022 to co-develop and co-commercialize an edocell, an

investigational car T-cell therapy for patients

with the blood cancer multiple myeloma. Gilead, said the acquisition of Arcelix, gives it full

control of an edo cell, and said it expects to complete the acquisition during the second quarter.

Renault said it would acquire Volvo Groups and CMAMA CGM's remaining stake in electric van of

flexis for an undisclosed sum. The joint venture was established by the three companies in 2024.

The French carmaker said it'll take full ownership of flexus and carry the project through completion,

overseeing the development of its new fully electric range of light commercial vehicles.

The agreement still needs regulatory approval. And Nvidia chips for laptop computers are set to hit

the market this year in products from Dell, Lenovo, and others. The move marks a return to the consumer

PC market for the leader in AI chips. Analysts say

NVIDIA wants to keep a connection with consumers in an era where every device will be AI-enabled.

For the PC chip, NVIDIA is collaborating with Intel and with Taiwanese chip designer MediaTech.

And that's your TNB Tech Minute. We'll be back this afternoon with more.